Bausch + Lomb Corporation (BLCO)
NYSE · Healthcare
Bausch + Lomb Corporation Shareholder Equity 2020–2025
Bausch + Lomb Corporation annual shareholder equity history from 2021 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bausch + Lomb Corporation shareholder equity as of December 31, 2025: 6.45B, a 0.39% decrease year-over-year.
- Bausch + Lomb Corporation shareholder equity for 2025 were 6.45B, a 0.39% decrease from 2024.
- Bausch + Lomb Corporation shareholder equity for 2024 were 6.47B, a 5.50% decrease from 2023.
- Bausch + Lomb Corporation shareholder equity for 2023 were 6.85B, a 2.60% decrease from 2022.
- Bausch + Lomb Corporation shareholder equity for 2022 were 7.03B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bausch + Lomb Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $6,448 |
| 2024 | $6,473 |
| 2023 | $6,850 |
| 2022 | $7,033 |
| 2021 | $9,329 |
Bausch + Lomb Corporation Shareholder Equity — FAQ
Bausch + Lomb Corporation (BLCO) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BLCO's shareholder equity history?
The chart and table above show Bausch + Lomb Corporation's shareholder equity by year and by quarter, including the growth rate.